NCT05755113 2026-03-12
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
QBiotics Group Limited
Phase 2 Recruiting
Clinical Trials
4 trialsNCT05608876 2025-08-07
A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer
QBiotics Group Limited
Phase 2 Active not recruiting
NCT05234437 2023-04-19
A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma
QBiotics Group Limited
Phase 2 Terminated
NCT04834973 2023-04-18
A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma
QBiotics Group Limited
Phase 1/2 Terminated